Live Database

Opportunities
Search

Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.

Searching the internal opportunities database and preparing the best matching records.
All Tenders Grants Funding Projects
44764 opportunities · Page 1536 of 1791
Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
RES
Fast Track to Innovation for breakthroughs in the Chemical Industry Action Plan (Research and Innovation Action)
ec.europa.eu
Expected Outcome:Proposals should describe a credible pathway from their project results and outcomes towards the expected impact of this Destination;...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: not specified - 2,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Proposals should describe a credible pathway from their project results and outcomes towards the expected impact of this Destination;Enable the acceleration of the market uptake of groundbreaking innovations in the decarbonisation of the chemical industries as well as alternatives to substances of concern. Scope:This open topic aims to speed up the adoption of new, groundbreaking innovations (starting TRL 4 ) as part of the Chemical Industry Action Plan, in the areas of decarbonisation of energy intensive industries, circular economy or breakthrough production technologies; as well as development of alternatives (new chemical substances, advanced materials or technologies) to substances of concern. Application of the SSbD Framework should be considered as appropriate.
RES
Innovative advanced materials and new production processes – reducing dependencies on Critical and Strategic Raw Materials (IA) (Innovative Advanced Materials for the EU and Processes4Planet partnerships)
ec.europa.eu
Expected Outcome:Reducing dependencies of critical and strategic raw materials through partial or total substitution by safe and sustainable innovativ...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 6,000,000 EUR - 7,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Reducing dependencies of critical and strategic raw materials through partial or total substitution by safe and sustainable innovative advanced materials and/or via more efficient use of critical and strategic raw materials in production processes;Speeding up the innovation cycle within value chain(s) important for European industry;Enhancing competitiveness of the industries and operational costs, while making supply chains more secure;New or improved production processes, innovative advanced materials and products that are safer and more sustainable, supporting a clean and autonomous economy; andDemonstrating how the safe and sustainable by design (SSbD) chemicals and materials framework can guide innovation. Scope:The focus of this topic is on alternatives for the substitution or more efficient use of critical and strategic raw materials[1]. The design and development...
RES
Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative Advanced Materials for the EU and Made in Europe partnerships)
ec.europa.eu
Expected Outcome:Innovative advanced materials designed for circularity are adopted in products faster, through accelerated production and technology...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 5,000,000 EUR - 6,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Innovative advanced materials designed for circularity are adopted in products faster, through accelerated production and technology uptake;Business models become available to enhance the use of circular advanced materials in strategic value chains; andResource efficiency (materials and energy) is increased significantly through a focus on circular advanced materials. Quality standards, harmonisation and regulatory requirements are addressed facilitating simplified market transition. Scope:The focus of this topic is on enabling circularity and resilient supply networks through R&I in advanced materials, in particular recyclable polymers and composites, magnets and metal (alloys) for additive manufacturing, and on accelerating their pathway to market. Proposals should develop new innovative advanced materials (IAMs) with superior or novel functionalities designed for circ...
RES
Expert network on Critical raw materials (CSA)
ec.europa.eu
Expected Outcome:Strengthening the expert capacity in the EU in a wide range of raw materials along the whole value chain;Better informed and more eff...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 3,000,000 EUR - 3,000,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Strengthening the expert capacity in the EU in a wide range of raw materials along the whole value chain;Better informed and more effective decision-making by the EU and National policy makers and the producers and users of raw materials regarding the supply and demand of raw materials and the associated environmental and social aspects;Improved EU official statistics and building the EU knowledge base of primary and secondary raw materials. Scope:Actions should strengthen an EU expert network and community covering all raw materials screened in the critical raw materials assessment of 2027. Flexibility in screening additional raw materials will be an added value.The consortium should build the EU expert community covering each screened raw material with expertise on primary and secondary resources; production, including exploration, mining, processing, recycling and ref...
RES
Pilot access schemes to Technology Infrastructures for European startups, scaleups and innovative SMEs (CSA)
ec.europa.eu
Expected Outcome:Proposals should demonstrate the following expected outcomes:A sound understanding of the specific needs of industrial users (includi...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 1,500,000 EUR - 2,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Proposals should demonstrate the following expected outcomes:A sound understanding of the specific needs of industrial users (including but not limited to innovative SMEs, startups and scaleups) for Technology infrastructure services in specific priority areas including but not limited to advanced materials, clean energy, or health and biotechnology;Increased opportunities for industrial users for development, testing, up-scaling and deployment of new technologies via the use of services offered by Technology Infrastructures;Strengthened innovation and technology development capacity of European SMEs, startups and scaleups via improved access to Technology Infrastructures;Attractiveness and effectiveness of the developed access schemes for broadening the range of Technology Infrastructures users, especially for startups and scaleups, including with transnational access....
RES
Technologies for innovative processing of raw materials (IA)
ec.europa.eu
Expected Outcome:Increased recovery rates of valuable raw materials, particularly critical raw materials from low grade or complex ores and/or from mi...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 10,000,000 EUR - 12,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Increased recovery rates of valuable raw materials, particularly critical raw materials from low grade or complex ores and/or from mining waste;Increased economic performance in terms of higher material-, water-, energy- and cost-efficiency and flexibility in minerals processing and metallurgical processes; andImproved health, safety and environmental performance of the operations throughout the whole life cycle that is considered, including a reduction in waste, wastewater and generation of emissions of air pollutants and a better recovery of resources from generated waste, reducing the environmental footprint and contributing to biodiversity and ecosystems preservation. Scope:Actions should develop and validate / demonstrate pilot scale facility located in the EU integrating relevant processing and refining technologies for improved recovery of raw materials from low g...
RES
Advanced manufacturing for key products (IA) (Made in Europe partnership)
ec.europa.eu
Expected Outcome:Advanced manufacturing technology and machinery becomes available in Europe for the manufacturing of key and high-performance product...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 6,000,000 EUR - 8,000,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:Advanced manufacturing technology and machinery becomes available in Europe for the manufacturing of key and high-performance products;Where relevant, production becomes increasingly circular through the reuse of secondary raw materials; and/or innovative advanced materials are incorporated in manufactured products, leading to better performance and quality; Resource efficiency in terms of materials and energy is increased significantly; andCircularity, productivity and competitiveness are increased, and hence resilience of European industry is enhanced. Scope:This topic addresses technologies and machinery for advanced manufacturing, focusing on manufacturing excellence and on increasing circularity, including through the better use of innovative advanced materials and secondary raw materials. The focus is on key manufactured components and products that are competitive...
RES
Factory processes and automation for de- and re-manufacturing (RIA) (Made in Europe partnership)
ec.europa.eu
Expected Outcome:A viable industrial ecosystem for circularity in manufacturing industries emerges, enhancing both circularity and resilience;De-manuf...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 5,000,000 EUR - 6,500,000 EUR
DeadlineFeb 2, 2027
Expected Outcome:A viable industrial ecosystem for circularity in manufacturing industries emerges, enhancing both circularity and resilience;De-manufacturing technologies and practices become available, making decisive contributions to a European remanufacturing industry and market;Functions of products are retained, reused, upgraded or adapted through de-manufacturing and re-manufacturing; andSkills, standards and safety measures relevant to remanufacturing are developed. Scope:Proposals should focus on developing de-manufacturing and re-manufacturing technologies at the factory level, addressing at least three of the following:Technologies to efficiently analyse part condition and support predictive maintenance, including for re-manufactured parts or components of lower value, e.g. by combining multimodal sensor data, AI and human inputs;AI and robotic-assisted technologies, e.g. inno...
TEN
Ireland – Recreational, cultural and sporting services – The provision of suitable sites for adventure trips for CMETB students. Whether day trips, one over night or two over nights including weekends.
ted.europa.eu
Buyer: Cavan and Monaghan Education and Training Board | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2027-02-03
Tender Procurement Contract Ireland Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 3, 2027
Buyer: Cavan and Monaghan Education and Training Board | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2027-02-03
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 g), ATC D11AX18 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Edoxaban, ATC B01AF03 für die Zeit 01.04.2025 - 31.03.2026 (zzgl. Verlängerungsoption 1 x 12 Monate)
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Opipramol, ATC N06AA05
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fluticason und Azelastin, ATC R01AD28
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rotigotin, ATC N04BC09
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enoxaparin (ausschließlich IFE 100 mg N2), ATC B01AB05 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Oxybutynin (ausschließlich FER/IST), ATC G04BD04 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Golimumab, ATC L04AB06
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ciclosporin, ATC S01XA18 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril und Amlodipin, ATC C09BB04 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 mg), ATC D11AX18 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Evolocumab, ATC C10AX13 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab, ATC M05BX06 für die Zeit 01.04.2025 - 31.03.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05
TEN
Lithuania – Works for complete or part construction and civil engineering work – Vaikų žaidimo įrenginiai (aikštelės) ir jų įrengimas
ted.europa.eu
Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05
Tender Procurement Contract Lithuania Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05
TEN
Lithuania – Overhaul and refurbishment work – Negyvenamųjų pastatų paprastojo remonto darbai
ted.europa.eu
Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05
Tender Procurement Contract Lithuania Open
AmountNot provided on the source page. Please check the official source.
DeadlineFeb 5, 2027
Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05
📅 Best viewed on desktop - or rotate your phone to landscape mode.
# Opportunity Type Region / Country Amount Deadline Source
38376 Fast Track to Innovation for breakthroughs in the Chemical Industry Action Plan (Research and Innovation Action) Expected Outcome:Proposals should describe a credible pathway from their project results and outcomes towards the expected impact... Research Funding Cash Grant Europe Expected EU contribution: not specified - 2,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Proposals should describe a credible pathway from their project results and outcomes towards the expected impact of this Destination;Enable the acceleration of the market uptake of groundbreaking innovations in the decarbonisation of the chemical industries as well as alternatives to substances of concern. Scope:This open topic aims to speed up the adoption of new, groundbreaking innovations (starting TRL 4 ) as part of the Chemical Industry Action Plan, in the areas of decarbonisation of energy intensive industries, circular economy or breakthrough production technologies; as well as development of alternatives (new chemical substances, advanced materials or technologies) to substances of concern. Application of the SSbD Framework should be considered as appropriate.

38377 Innovative advanced materials and new production processes – reducing dependencies on Critical and Strategic Raw Materials (IA) (Innovative Advanced Materials for the EU and Processes4Planet partnerships) Expected Outcome:Reducing dependencies of critical and strategic raw materials through partial or total substitution by safe and s... Research Funding Cash Grant Europe Expected EU contribution: 6,000,000 EUR - 7,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Reducing dependencies of critical and strategic raw materials through partial or total substitution by safe and sustainable innovative advanced materials and/or via more efficient use of critical and strategic raw materials in production processes;Speeding up the innovation cycle within value chain(s) important for European industry;Enhancing competitiveness of the industries and operational costs, while making supply chains more secure;New or improved production processes, innovative advanced materials and products that are safer and more sustainable, supporting a clean and autonomous economy; andDemonstrating how the safe and sustainable by design (SSbD) chemicals and materials framework can guide innovation. Scope:The focus of this topic is on alternatives for the substitution or more efficient use of critical and strategic raw materials[1]. The design and development...

38378 Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative Advanced Materials for the EU and Made in Europe partnerships) Expected Outcome:Innovative advanced materials designed for circularity are adopted in products faster, through accelerated produc... Research Funding Cash Grant Europe Expected EU contribution: 5,000,000 EUR - 6,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Innovative advanced materials designed for circularity are adopted in products faster, through accelerated production and technology uptake;Business models become available to enhance the use of circular advanced materials in strategic value chains; andResource efficiency (materials and energy) is increased significantly through a focus on circular advanced materials. Quality standards, harmonisation and regulatory requirements are addressed facilitating simplified market transition. Scope:The focus of this topic is on enabling circularity and resilient supply networks through R&I in advanced materials, in particular recyclable polymers and composites, magnets and metal (alloys) for additive manufacturing, and on accelerating their pathway to market. Proposals should develop new innovative advanced materials (IAMs) with superior or novel functionalities designed for circ...

38379 Expert network on Critical raw materials (CSA) Expected Outcome:Strengthening the expert capacity in the EU in a wide range of raw materials along the whole value chain;Better i... Research Funding Cash Grant Europe Expected EU contribution: 3,000,000 EUR - 3,000,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Strengthening the expert capacity in the EU in a wide range of raw materials along the whole value chain;Better informed and more effective decision-making by the EU and National policy makers and the producers and users of raw materials regarding the supply and demand of raw materials and the associated environmental and social aspects;Improved EU official statistics and building the EU knowledge base of primary and secondary raw materials. Scope:Actions should strengthen an EU expert network and community covering all raw materials screened in the critical raw materials assessment of 2027. Flexibility in screening additional raw materials will be an added value.The consortium should build the EU expert community covering each screened raw material with expertise on primary and secondary resources; production, including exploration, mining, processing, recycling and ref...

38380 Pilot access schemes to Technology Infrastructures for European startups, scaleups and innovative SMEs (CSA) Expected Outcome:Proposals should demonstrate the following expected outcomes:A sound understanding of the specific needs of indus... Research Funding Cash Grant Europe Expected EU contribution: 1,500,000 EUR - 2,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Proposals should demonstrate the following expected outcomes:A sound understanding of the specific needs of industrial users (including but not limited to innovative SMEs, startups and scaleups) for Technology infrastructure services in specific priority areas including but not limited to advanced materials, clean energy, or health and biotechnology;Increased opportunities for industrial users for development, testing, up-scaling and deployment of new technologies via the use of services offered by Technology Infrastructures;Strengthened innovation and technology development capacity of European SMEs, startups and scaleups via improved access to Technology Infrastructures;Attractiveness and effectiveness of the developed access schemes for broadening the range of Technology Infrastructures users, especially for startups and scaleups, including with transnational access....

38381 Technologies for innovative processing of raw materials (IA) Expected Outcome:Increased recovery rates of valuable raw materials, particularly critical raw materials from low grade or complex... Research Funding Cash Grant Europe Expected EU contribution: 10,000,000 EUR - 12,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Increased recovery rates of valuable raw materials, particularly critical raw materials from low grade or complex ores and/or from mining waste;Increased economic performance in terms of higher material-, water-, energy- and cost-efficiency and flexibility in minerals processing and metallurgical processes; andImproved health, safety and environmental performance of the operations throughout the whole life cycle that is considered, including a reduction in waste, wastewater and generation of emissions of air pollutants and a better recovery of resources from generated waste, reducing the environmental footprint and contributing to biodiversity and ecosystems preservation. Scope:Actions should develop and validate / demonstrate pilot scale facility located in the EU integrating relevant processing and refining technologies for improved recovery of raw materials from low g...

38382 Advanced manufacturing for key products (IA) (Made in Europe partnership) Expected Outcome:Advanced manufacturing technology and machinery becomes available in Europe for the manufacturing of key and high... Research Funding Cash Grant Europe Expected EU contribution: 6,000,000 EUR - 8,000,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Advanced manufacturing technology and machinery becomes available in Europe for the manufacturing of key and high-performance products;Where relevant, production becomes increasingly circular through the reuse of secondary raw materials; and/or innovative advanced materials are incorporated in manufactured products, leading to better performance and quality; Resource efficiency in terms of materials and energy is increased significantly; andCircularity, productivity and competitiveness are increased, and hence resilience of European industry is enhanced. Scope:This topic addresses technologies and machinery for advanced manufacturing, focusing on manufacturing excellence and on increasing circularity, including through the better use of innovative advanced materials and secondary raw materials. The focus is on key manufactured components and products that are competitive...

38383 Factory processes and automation for de- and re-manufacturing (RIA) (Made in Europe partnership) Expected Outcome:A viable industrial ecosystem for circularity in manufacturing industries emerges, enhancing both circularity and... Research Funding Cash Grant Europe Expected EU contribution: 5,000,000 EUR - 6,500,000 EUR Open Feb 2, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:A viable industrial ecosystem for circularity in manufacturing industries emerges, enhancing both circularity and resilience;De-manufacturing technologies and practices become available, making decisive contributions to a European remanufacturing industry and market;Functions of products are retained, reused, upgraded or adapted through de-manufacturing and re-manufacturing; andSkills, standards and safety measures relevant to remanufacturing are developed. Scope:Proposals should focus on developing de-manufacturing and re-manufacturing technologies at the factory level, addressing at least three of the following:Technologies to efficiently analyse part condition and support predictive maintenance, including for re-manufactured parts or components of lower value, e.g. by combining multimodal sensor data, AI and human inputs;AI and robotic-assisted technologies, e.g. inno...

38384 Ireland – Recreational, cultural and sporting services – The provision of suitable sites for adventure trips for CMETB students. Whether day trips, one over night or two over nights including weekends. Buyer: Cavan and Monaghan Education and Training Board | Notice type: cn-social | Procedure: open | Contract: services | Deadline:... Tender Procurement Contract Ireland Not provided on the source page. Please check the official source. Open Feb 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Cavan and Monaghan Education and Training Board | Notice type: cn-social | Procedure: open | Contract: services | Deadline: 2027-02-03

38385 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 g), ATC D11AX18 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38386 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Edoxaban, ATC B01AF03 für die Zeit 01.04.2025 - 31.03.2026 (zzgl. Verlängerungsoption 1 x 12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38387 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Opipramol, ATC N06AA05 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38388 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fluticason und Azelastin, ATC R01AD28 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38389 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rotigotin, ATC N04BC09 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38390 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38391 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enoxaparin (ausschließlich IFE 100 mg N2), ATC B01AB05 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38392 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Oxybutynin (ausschließlich FER/IST), ATC G04BD04 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38393 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Golimumab, ATC L04AB06 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38394 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ciclosporin, ATC S01XA18 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38395 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril und Amlodipin, ATC C09BB04 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38396 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 mg), ATC D11AX18 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38397 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Evolocumab, ATC C10AX13 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38398 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab, ATC M05BX06 für die Zeit 01.04.2025 - 31.03.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-02-05

38399 Lithuania – Works for complete or part construction and civil engineering work – Vaikų žaidimo įrenginiai (aikštelės) ir jų įrengimas Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline... Tender Procurement Contract Lithuania Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05

38400 Lithuania – Overhaul and refurbishment work – Negyvenamųjų pastatų paprastojo remonto darbai Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline... Tender Procurement Contract Lithuania Not provided on the source page. Please check the official source. Open Feb 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Vilniaus miesto savivaldybės administracija | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-02-05